All stocks / BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH
Bioforce Nanosciences Holdings (BFNH): a late 10-Q notice in May 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BIOFORCE NANOSCIENCES HOLDINGS INC
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Last trade
- Nov 16
- Website
- www.bioforcenano.com
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($1,291,951)
It spends more than it earns
Under strainThe company lost $1.3 million in the year. It reported no sales.
- Cash and cash equivalents
- $786
- Net cash used in operating activities
- ($65,150)
The cash could run out soon
Under strainIt had $786 in the bank and used about $5,429 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $786
- Total liabilities
- $619,329
It owes more than it owns
Under strainEverything the company owns adds up to $786. Its debts and unpaid bills add up to $619,329. That is about $787.95 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 36,831,467 shares as of 2026-11-06: 38,065,914 outstanding minus 1,234,447 held by 2 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-05-13: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-03-31: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-09 | 10-Q | QTR. REPORT - SEPT. 30, 2026 |
| 2026-10-07 | 8-K | CURRENT REPORT |
| 2026-09-04 | 3 | PRIMARY DOCUMENT |
| 2026-09-04 | 8-K | CURRENT REPORT |
| 2026-09-04 | SCHEDULE 13D | |
| 2026-09-03 | 3 | PRIMARY DOCUMENT |
| 2026-09-02 | 4 | PRIMARY DOCUMENT |
| 2026-09-02 | 4 | PRIMARY DOCUMENT |
| 2026-08-18 | 8-K | CURRENT REPORT |
| 2026-08-14 | 8-K | CURRENT REPORT |
| 2026-08-10 | 10-Q | QTR. REPORT - JUNE 30, 2026 |
| 2026-07-07 | 8-K | CURRENT REPORT |
Common questions about BFNH
Does BFNH file reports with the SEC?
Yes. Bioforce Nanosciences Holdings files with the SEC under company number 0001310488. The most recent filing we hold is a 10-Q dated 2026-11-09.
Source recordHow many BFNH shares are outstanding?
38,065,914 shares as of 2026-11-06, as reported to the SEC.
Source recordHas BFNH filed reports late?
Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-05-13. A notice means a report was not ready on time; check whether the report followed.
Source recordWho runs Bioforce Nanosciences Holdings?
Officers named in its insider filings: Richard Kaiser Kaiser (CEO & CFO).
Source recordIs Bioforce Nanosciences Holdings making money?
The company lost $1.3 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record